Brief: Terumo Says It And Wuxi Biologics Enter Into Agreement On A Drug Product Plant In Leverkusen, Germany
May 14 (Reuters) - WuXi Biologics (Cayman) Inc 2269.HK: TERUMO SAYS IT AND WUXI BIOLOGICS ENTER INTO AGREEMENT ON A DRUG PRODUCT PLANT IN LEVERKUSEN, GERMANY Source text: [ID:] Further company coverage: 2269.HK
Recent news on WuXi Biologics (Cayman)
See all newsHong Kong stocks end higher on pharma, tech gains
Hong Kong stocks climb, led by pharmaceutical, tech stocks
CanSino leads HK-listed vaccine makers lower as BioNTech halts mRNA trial
WuXi Biologics H1 net profit up on margin expansion
Brief: WuXi Biologics Logs HY Net Profit Attributable RMB 2,439.8 Mln